Startseite>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>DL-Mevalonolactone

DL-Mevalonolactone (Synonyms: DL-Mevalonic Acid Lactone, (±)-Mevalonolactone, NSC 90804)

Katalog-Nr.GC40495

DL-Mevalonolacton ((±)-Mevalonolacton; Mevalolacton) ist die δ-Lacton-Form von MevalonsÄure, einem VorlÄufer im Mevalonat-Weg.

Products are for research use only. Not for human use. We do not sell to patients.

DL-Mevalonolactone Chemische Struktur

Cas No.: 674-26-0

Größe Preis Lagerbestand Menge
250mg
65,00 $
Auf Lager
500mg
123,00 $
Auf Lager
1g
233,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

DL-Mevalonolactone ((±)-Mevalonolactone;Mevalolactone) is the δ-lactone form of mevalonic acid, a precursor in the mevalonate pathway. DL-Mevalonolactone (Mevalonolactone) decreases mitochondrial membrane potential (∆Ψm), NAD(P)H content and the capacity to retain Ca2+ in the brain, besides inducing mitochondrial swelling[1][2].

References:
[1]. Domingos SR, et al. On the structural intricacies of a metabolic precursor: Direct spectroscopic detection of water-induced conformational reshaping of mevalonolactone. J Chem Phys. 2017 Sep 28;147(12):124310.
[2]. Cecatto C, et al. Mevalonolactone disrupts mitochondrial functions and induces permeability transition pore opening in rat brain mitochondria: Implications for the pathogenesis of mevalonic aciduria. Neurochem Int. 2017 Sep;108:133-145.

Bewertungen

Review for DL-Mevalonolactone

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for DL-Mevalonolactone

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.